A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease

Nature Genetics

Volumn 13, Issue 4, 1996, Pages 422-428

  Gow, Alexander ^a   Lazzarini, Robert A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MESSENGER RNA; MUTANT PROTEIN; PROTEOLIPID PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOPLASMIC RETICULUM; GENE MUTATION; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; PELIZAEUS MERZBACHER DISEASE; PRIORITY JOURNAL; PROTEIN TRANSPORT;

ALLELES; ALTERNATIVE SPLICING; ANIMALS; CELL COMPARTMENTATION; CELL LINE; CERCOPITHECUS AETHIOPS; DIFFUSE CEREBRAL SCLEROSIS OF SCHILDER; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; LYSOSOMES; MICE; MICE, JIMPY; MICROSCOPY, CONFOCAL; MYELIN PROTEOLIPID PROTEIN; NERVE TISSUE PROTEINS; PROTEIN FOLDING; RECOMBINANT PROTEINS;

ANIMALIA;

EID: 0030036917     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0896-422     Document Type: Article

References (65)

1. Boespflug-Tanguy, O. et al. Genetic homogeneity of Pelizaeus-Merzbacher disease: tight linkage to the proteolipoprotein locus in 16 affected families. Am. J. Hum. Genet. 55, 461-467 (1994).
2. Hodes, M., Pratt, V. & Dlouhy, S. Genetics of Pelizaeus-Merzbacher disease. Dev. Neurosci. 15, 383-394 (1993).
3. Hodes, M. & Dlouhy, S. The changing phenotype of Pelizaeus-Merzbacher disease. Am. J. Hum. Genet. 57, A92 (1995).
4. McKusick, V. Mendilian Inheritance in Man. (Johns Hopkins University Press, Baltimore, 1994).
5. Kaye, E., Doll, R., Natowicz, M. & Smith, F. Pelizaeus-Merzbacher disease presenting as spinal muscular atrophy: clinical and molecular studies. Ann. Neurol. 36, 916-919 (1994).
6. Nance, M. et al. Adult-onset neurological disorder in a Pelizaeus-Merzbacher disease carrier mother. Am. J. Hum. Genet. 53, 1745 (1993).
7. Kobayashi, H., Hoffman, E. & Marks, H. The rumpshaker mutation in spastic paraplegia. Nature Genet. 7, 351-352 (1994).
8. Saugier-Veber, P. et al. X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nature Genet 6, 257-262 (1994).
9. Hudson, L.D. & Nadon, N.L. in Myelin: Biology and Chemistry. (ed. Martenson, R.E.) 677-702 (CRC Press, Boca Raton, 1992).
10. Skoff, R. & Knapp, P. in Myelin: Biology and Chemistry. (ed. Martenson, R.) 653-676 (CRC Press, Boca Raton, 1992).
11. Gow, A., Friedrich, V., Jr & Lazzarini, R. Intracellular transport and sorting of the oligodendrocyte transmembrane proteolipid protein. J. Neurosci. Res. 37, 563-573 (1994).
12. Gow, A., Friedrich, V., Jr & Lazzarini, R. Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport. J. Neurosci. Res. 37, 574-583 (1994).
13. Rose, J.K. & Doms, R.W. Regulation of protein export from the endoplasmic reticulum. Annu. Rev. Cell Biol. 4, 257-288 (1988).
14. Hammond, C. & Helenius, A. Quality control in the secretory pathway. Curr. Opin. Cell Biol. 7, 523-529 (1995).
15. Schneider, A. et al. Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene. Nature 358, 758-761 (1992).
16. msd and comparison with jp and qk on their present genetic backgrounds. Brain Res. 194, 325-338 (1980).
17. Mitchell, L. et al. Developmental expression of major myelin protein genes in the CNS of X-linked hypomyelinating mutant rumpshaker. J. Neurosci. Res. 33, 205-217 (1992).
18. Tosic M., Dolivo, M., Amiguet, P., Domanska-Janik, K. & Matthieu, J.-M. Paralytic tremor (pt) rabbit: a sex-linked mutation affecting proteolipid protein-gene expression. Brain Res. 625, 307-312 (1993).
19. Tosic, M., Dolivo, M., Amiguet, P., Domanska-Janik, K. & Matthieu, J.-M. Paralytic tremor (pt): a new allele of the proteolipid protein gene in rabbits. J. Neurochem. 63, 2210-2216 (1994).
20. Gething, M.-J. & Sambrook, J. Transport and assembly processes in the endoplasmic reticulum. Semin. Cell Biol. 1, 65-72 (1990).
21. Tosic, M. et al. Proteolipid/DM20 proteins bearing the paralytic tremor mutation in peripheral nerves and transferred Cos-7 cells. Neurochem. Res. 21, 423-430 (1996).
22. Raposo, G., van Santen, H., Leijendekker, R., Geuze, H. & Ploegh, H. Misfolded major histocompatibility complex class I molecules accumulate in an expanded ER-Golgi intermediate compartment. J. Cell Biol. 131, 1403-1419 (1995).
23. Hammond, C. & Helenius, A. Quality control in the secretory pathway: retention of a misfolded viral membrane glycoprotein involves cycling between the ER, intermediate compartment and Golgi apparatus. J. Cell Biol. 126, 41-52 (1994).
24. Sinoway, M., Kitagawa, K., Timsit, S., Hashim, G. & Colman, D. Proteolipid protein interactions in transfectants: implications for myelin assembly. J. Neurosci. Res. 37, 551-562 (1994).
25. Hurtley, S.M. & Helenius, A Protein oligomerization in the endoplasmic reticulum. Annu. Rev. Cell Biol. 5, 277-307 (1989).
26. Puckett, C. et al. Myelin-specific proteolipid protein is expressed in myelinaling Schwann cells but is not incorporated into myelin sheaths. J. Neurosci. Res. 18, 511-518 (1987).
27. Bonifacino, J. & Lippincott-Schwartz, J. Degradation of proteins within the endoplasmic reticulum. Curr. Biol. 3, 592-600 (1991).
28. Ward, C., Omura, S. & Kopito, R. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83, 121-127 (1995).
29. Jensen, T. et al. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 83, 129-135 (1995).
30. 1-antitrypsin deficiency. Proc. Natl. Acad. Sci. USA 91, 9014-9018 (1994).
31. Milner, R. et al. Nucleotide sequences of two mRNAs for rat brain myelin proteolipid protein. Cell 42, 931-339 (1985).
32. Pfeiffer, S., Warrington, A. & Bansal, R. The oligodendrocyte and its many cellular processes. Trends Cell Biol. 3, 191-197 (1993).
33. Ellis, D. & Malcolm, S. Proteolipid protein gene dosage effect in Pelizaeus-Merzbacher disease. Nature Genet. 6, 333-334 (1994).
34. Kagawa, T. et al. Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron 13, 427-442 (1994).
35. Readhead, C., Schneider, A., Griffiths, I. & Nave, K.A. Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron 12, 583-595 (1994).
36. Nussbaum, J.L. & Roussel, G. Immunocytochemical demonstration of the transport of myelin proteins through the Golgi apparatus. Cell Tissue Res. 234, 647-559 (1983).
37. Roussel, G., Meskovic, N., Trifilieff, E., Artault, J.-C. & Nussbaum, J.-L. Arrest of proteolipid transport through the Golgi apparatus in Jimpy brain. J. Neurocytol. 16, 195-204 (1987).
38. Watanabe, I. et al. Early lesion of Pelizaeus-Merzbacher disease: electron microscopic and biochemical study. J. Neuropath. Exp. Neurol. 32, 313-333 (1973).
39. Duncan, I.D., Griffiths, I.R. & Munz, M. 'Shaking pups': a disorder of central myelination in the Spaniel dog. III. Quantitative aspects of glia and myelin in the spinal cord and optic nerve. Neuropathol. Appl. Neurobiol. 9, 355-368 (1983).
40. Dentinger, M.P., Barron, K.D. & Csiza, C.K. Ultrastructure of the central nervous system in a myelin deficient rat. J. Neurocytol. 11, 671-691 (1982).
41. Griffiths, I.R. et al. Rumpshaker mouse: a new X-linked mutation affecting myelination: evidence for a defect in PLP expression. J. Neurocytol. 19, 273-283 (1990).
42. Yoshioka, T., Feigenbaum, L. & Jay, G. Transgenic mouse model for central nervous system demyelination. Molec. cell. Biol. 11, 5479-5486 (1991).
43. Turnley, A.M. et al. Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature 353, 566-569 (1991).
44. Raskind, W.H., Williams, C.A., Hudson, L.D. & Bird, T.D. Complete deletion of the proteolipid protein gene (PLP) in a family with X-linked Pelizaeus-Merzbacher disease. Am. J. Hum. Genet. 49, 1355-1360 (1991).
45. Boison, D. & Stoffel, W. Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice. Proc. Natl. Acad. Sci. USA 91, 11709-11713 (1994).
46. Boison, D., Bussow, H., D'Urso, D., Muller, H.-W. & Stoffel, W. Adhesive properties of proteolipid protein are responsible for the compaction of CNS myelin sheaths. J. Neurosci. 15, 5502-5513 (1995).
47. Weimbs, T. & Stoffel, W. Proteolipid protein (PLP) of CNS myelin - positions of free, disulfide-bonded, and fatty acid thioester-linked cysteine residues and implications for the membrane topology of PLP. Biochemistry 31, 12289-12296 (1992).
48. Scheffer, I., Baraitser, M., Harding, W., Kendall, B. & Brett, E. Pelizaeus-Merzbacher disease: classical or connatal? Neuropediatrics 22, 71-78 (1991).
49. Seitelberger, F. in Handbook of Clinical Neurology: Leukodystrophies and Polydystrophies. (eds. Vinken, P. & Bruyn, G.) 150-202 (North-Holland, Amsterdam, 1970).
50. Boulloche, J. & Aicardi, J. Pelizaeus-Merzbacher disease: clinical and nosological study. J. Child Neurol. 1, 223-239 (1986).
51. Timsit, S. et al. The DM20 protein of myelin: intracellular and surface expression patterns in transfectants. J. Neurochem. 58, 1936-1942 (1992).
52. Bole, D., Hendershot, L. & Kearney, J. Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting and secreting hybridomas. J. Cell Biol. 102, 1558-1566 (1986).
53. Mane, S. et al. Purification and characterization of human lysosomal membrane glycoproteins. Arch. Biochem. Biophys. 268, 360-378(1989).
54. Yamamura, T., Konola, J.T., Wekerle, H. & Lees, M.B. Monoclonal antibodies against myelin proteolipid protein: identification and characterization of two major determinants. J. Neurochem. 57, 1671-1680 (1991).
55. Hudson, L., Friedrich, V.L. Jr, Behar, T., Dubois-Dalcq, M. & Lazzarini, R.A. The initial events in myelin synthesis: orientation of proteolipid protein in the plasma membrane of cultured oligodendrocytes. J. Cell Biol. 109, 717-727 (1989).
56. Hudson, L., Puckett, C., Berndt, J., Chan, J. & Gencic, S. Mutation of the proteolipid protein gene PLP in a human X chromosome-linked myelin disorder. Proc. Natl. Acad. Sci. USA 86, 8128-8131 (1989).
57. Koeppen, A. in Myelin: Biology and Chemistry. (ed. Martenson, R.) 703-721 (CRC Press, Boca Raton, 1992).
58. 223→pro in the proteolipid protein gene, and prenatal diagnosis. Am. J. Hum. Genet. 51, 871-878 (1992).
59. Weimbs, T., Dick, T., Stoffel, W. & Boltshauser, E. A point mutation at the X-chromosomal proteolipid protein locus in Palizaeus-Merzbacher disease leads to disruption of myelinogenesis. Biol. Chem. Hoppe-Seyler 371, 1175-1183 (1990).
60. Pratt, V. et al. A new mutation in the proteolipid protein (PLP) gene in a German family with Pelizaeus-Merzbacher disease. Am. J. Med. Genet. 38, 136-139 (1991).
61. Doll, R., Natowicz, M.R., Schiffmann, R. & Smith, F.I. Molecular diagnostics for myelin proteolipid protein gene mutations in Pelizaeus-Merzbacher disease. Am. J. Hum. Genet. 51, 161-169 (1992).
62. Gencic, S., Abuelo, D., Ambler, M. & Hudson, L.D. Pelizaeus-Merzbacher disease: an X-linked neurologic disorder of myelin metabolism with a novel mutation in the gene encoding proteolipid protein. Am. J. Hum. Genet. 45, 435-442 (1989).
63. Pham-Dinh, D. et al. Pelizaeus-Merzbacher disease: a valine to phenytalanine point mutation in a putative extracellular loop of proteolipid. Proc. Natl. Acad. Sci. USA 88, 7562-7566 (1991).
64. msd mice. J. Neurosci. 10, 117-124 (1990).
65. Popot, J.L., Pham Dinh, D. & Dautigny, A. Major Myelin proteolipid: the 4-alpha-helix topology. J. Membr. Biol. 120, 233-246 (1991).